Skip to main content

Recognition and treatment of genitourinary complications in paediatric Crohn’s disease using Infliximab

Buy Article:

$48.00 plus tax (Refund Policy)

Abstract:

Abstract

Although genitourinary complications of Crohn’s are well recognized, available information regarding their clinical course and management is sparse especially in the paediatric population. We report a myriad of urological complications in five paediatric cases, our experience from a tertiary paediatric urological and gastroenterological centre. All children with urological complications had severe Crohn’s disease which necessitated the use of immuno-suppressants including Infliximab. Three of four children healed and closed their fistulas after treatment, although failed to avoid future surgery, albeit for other reasons. Conclusion: 

We suggest Infliximab should be considered as a treatment option but in the absence of a common consensus, treatment be tailored to individual cases.

Keywords: Crohn’s disease; Fistula; Inflammatory bowel disease; Infliximab; Nephrolithiasis; Paediatrics; Renal; Stone; Surgery; Urinary tract

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1651-2227.2010.01731.x

Affiliations: 1: Department of Paediatrics, Southampton University Hospital NHS Trust, Southampton, UK 2: Paediatric Urology Department, Great Ormond Street Hospital, London, UK 3: Department of Paediatric Gastroenterology, Great Ormond Street Hospital, London, UK

Publication date: July 1, 2010

bpl/apa/2010/00000099/00000007/art00020
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more